Home » Market News » DirectorsTalk Highlights » Allergy Therapeutics plc Opportunities in the US
Allergy therapeutics plc

Allergy Therapeutics plc Opportunities in the US

Allergy Therapeutics plc (LON:AGY) Finance Director Nick Wykeman and Chief Executive Officer Manuel Llobet spoke to Proactive Investors about another year of strong growth for the company.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.